Universal Health Services, Inc. (UHS) Shareholder/Analyst Call Prepared Remarks Transcript
Universal Health Services, Inc. (UHS) Shareholder/Analyst Call Prepared Remarks Transcript
UHS - Universal Health Services, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$226.00
DETAILS
HIGH:
$310.00
LOW:
$190.00
MEDIAN:
$211.00
CONSENSUS:
$226.00
UPSIDE:
43.22%
Stock News
Universal Health Services, Inc. (UHS) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Universal Health Services, Inc. (UHS) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Here's Why Universal Health Services (UHS) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
First Eagle U.S. Fund Q1 2026 Portfolio Review
U.S. Fund A Shares (without sales charge*) posted a return of 1.17% in first quarter 2026. Leading contributors in the First Eagle U.S. Fund this quarter included gold bullion, Exxon Mobil Corporation, Noble Corporation PLC Class A, IPG Photonics Corporation and SLB Limited. The leading detractors in the quarter were Workday, Inc. Class A, Oracle Corporation, Salesforce.com, Inc., Meta Platforms, Inc. Class A and Universal Health Services, Inc, Class B.
UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT BOFA SECURITIES HEALTH CARE CONFERENCE
KING OF PRUSSIA, Pa., April 30, 2026 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) is scheduled to present at the BofA Securities Health Care Conference on May 12, 2026, at 1:40pm PT.
Why Universal Health Services (UHS) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
UHS' Q1 Earnings Beat on Strong Behavioral Health Care Admissions
Universal Health tops Q1 estimates as behavioral health admissions and patient days rise, driving revenue growth despite higher operating costs.
Universal Health Services, Inc. (UHS) Q1 2026 Earnings Call Transcript
Universal Health Services, Inc. (UHS) Q1 2026 Earnings Call Transcript
Universal Health Services (UHS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Universal Health Services (UHS) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Universal Health Services (UHS) Q1 Earnings and Revenues Surpass Estimates
Universal Health Services (UHS) came out with quarterly earnings of $5.62 per share, beating the Zacks Consensus Estimate of $5.29 per share. This compares to earnings of $4.84 per share a year ago.
UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THREE-MONTH PERIOD ENDED MARCH 31, 2026
Consolidated Results of Operations, As Reported and As Adjusted – Three-month periods ended March 31, 2026 and 2025: KING OF PRUSSIA, Pa., April 27, 2026 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that its reported net income attributable to UHS was $348.7 million, or $5.65 per diluted share, during the first quarter of 2026, as compared to $316.7 million, or $4.80 per diluted share, during the first quarter of 2025.
Why Universal Health Services (UHS) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Countdown to Universal Health Services (UHS) Q1 Earnings: Wall Street Forecasts for Key Metrics
Beyond analysts' top-and-bottom-line estimates for Universal Health Services (UHS), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2026.
Will Acute Care Strength Help Universal Health Offset Q1 Rising Costs?
UHS heads into Q1 earnings with acute care and behavioral health growth, but rising labor and supply costs could cloud the outlook.
Universal Health Services, Inc. $UHS Shares Sold by Consolidated Investment Group LLC
Consolidated Investment Group LLC trimmed its holdings in Universal Health Services, Inc. (NYSE: UHS) by 19.6% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 18,485 shares of the health services provider's stock after selling 4,500 shares during the period. Consolidated Investment Group
Universal Health Services Is A Huge Bargain At 8x Earnings Vs HCA At 16x
Universal Health Services (UHS) trades at a decade-low valuation despite strong EPS growth and robust capital returns. UHS guides for 2026 revenue, EBITDA, and EPS growth of 7%, 5%, and 9% at the midpoint, outpacing peer HCA. Key risks include ACA subsidy expirations and Medicaid reimbursement cuts, but downside appears priced in at current levels.
3 Oversold Healthcare Stocks to Buy After Jobs Data
The March jobs report released on April 3 showed an impressive 178,000 jobs were created. Of that number, 76,000 were in the healthcare sector.
Massachusetts Financial Services Co. MA Lowers Stock Position in Universal Health Services, Inc. $UHS
Massachusetts Financial Services Co. MA lowered its position in Universal Health Services, Inc. (NYSE: UHS) by 3.2% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 891,270 shares of the health services provider's stock after selling 29,175
UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DATE FOR FIRST QUARTER 2026 EARNINGS RELEASE AND CONFERENCE CALL
KING OF PRUSSIA, Pa., April 6, 2026 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that it will report results for its first quarter ended March 31, 2026, after the market closes on Monday, April 27, 2026.
4 Stocks to Watch in a Rapidly Transforming Hospital Industry
The Zacks Medical-Hospital industry is evolving as demand rises, care shifts beyond hospitals, and consolidation picks up. Tenet Healthcare, Universal Health, Acadia and Community Health stand out.
Price Targets
Universal Health price target lowered to $310 from $320 at UBS
$310.00
(was $167.86)
UBS
Universal Health price target lowered to $194 from $229 at Cantor Fitzgerald
$194.00
(was $167.51)
Cantor Fitzgerald
Universal Health price target lowered to $190 from $216 at RBC Capital
$190.00
(was $162.54)
RBC Capital
Universal Health price target lowered to $211 from $238 at Guggenheim
$211.00
(was $162.54)
Guggenheim
Universal Health price target lowered to $204 from $241 at Baird
$204.00
(was $162.54)
Michael Ha
·
Robert W. Baird
Universal Health price target lowered to $238 from $268 at Barclays
$238.00
(was $179.51)
Barclays
Universal Health price target lowered to $262 from $263 at Barclays
$262.00
(was $203.68)
Barclays
Universal Health price target lowered to $245 from $251 at TD Cowen
$245.00
(was $214.97)
UBS
Universal Health downgraded to Equal Weight from Overweight at Wells Fargo
$235.00
(was $221.74)
Wells Fargo
Universal Health price target raised to $274 from $253 at Guggenheim
$274.00
(was $239.43)
Jason Cassorla
·
Guggenheim
Raymond James Upgrades Universal Health Services (UHS) to Outperform
$270.00
(was $217.01)
John Ransom
·
Raymond James
Universal Health price target raised to $231 from $206 at RBC Capital
$231.00
(was $225.30)
UBS
Universal Health Services (UHS) PT Raised to $231 at RBC Capital
$231.00
(was $223.61)
Ben Hendrix
·
RBC Capital
Universal Health price target raised to $302 from $280 at UBS
$302.00
(was $219.32)
UBS
Universal Health price target raised to $253 from $227 at Guggenheim
$253.00
(was $219.32)
Jason Cassorla
·
Guggenheim
Universal Health Services (UHS) PT Raised to $233 at Morgan Stanley
$233.00
(was $219.32)
Craig Hettenbach
·
Morgan Stanley
Universal Health price target raised to $263 from $250 at Barclays
$263.00
(was $214.03)
Barclays
Mizuho Reiterates Outperform Rating on Universal Health Services (UHS)
$242.00
(was $214.03)
Ann Hynes
·
Mizuho Securities
Universal Health assumed with a Neutral at Goldman Sachs
$219.00
(was $197.76)
Goldman Sachs
Universal Health price target raised to $249 from $210 at Wells Fargo
$249.00
(was $209.11)
Wells Fargo